| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |